Simultaneous detection of sibutramine and phenolphthalein in a diet jelly health food product that caused health problems

Tomohide Fukiwake,Sachiyo Oosawa,Hiroki Yoshino,Tatsuya Shinozuka,Maki Nishimura,Rie Ito,Hiroshi Akiyama
DOI: https://doi.org/10.1007/s44211-022-00217-0
IF: 1.967
2022-12-07
Analytical Sciences
Abstract:The Public Health Center in Chiba Prefecture, Japan, received a consultation from a resident of Chiba Prefecture who consumed a diet jelly health food product and experienced health problems. To investigate the cause of the health problems, we examined the two food products for the presence of pharmaceutical ingredients. A screening analysis using ultra-high-performance liquid chromatography with a photodiode array detector (UPLC–PDA) indicated the presence of sibutramine and phenolphthalein in the food product. Analysis using an ultra-high-performance liquid chromatography–quadrupole-Kingdon trap mass spectrometer (UHPLC–Q-Kingdon trap MS) confirmed the presence of sibutramine and phenolphthalein. Quantitative analysis using UPLC–PDA showed that sibutramine and phenolphthalein were present at 15 and 16 mg/bag and 2.4 and 2.6 mg/bag, respectively. According to the drug insert for sibutramine capsules in the United States, the recommended medicinal dose of sibutramine should not exceed 15 mg/day, and the amount ingested in the present case exceeded that value. The present study results indicated that ingestion of the jelly health food product may cause health problems.
chemistry, analytical
What problem does this paper attempt to address?